Alpha Tau registers for a dual listing on the Tel Aviv Stock Exchange
Arx congratulates Alpha Tau Medical (Nasdaq: DRTS) on registering to dual-list on the Tel Aviv Stock Exchange, after crossing a $1 billion valuation. Shares are expected to trade on TASE under DRTS (Hebrew: דרטס), alongside the existing Nasdaq listing.
“After the astounding achievements that Alpha Tau has made these last few years, it brings me great pride to say: we are coming home,” said CEO Uzi Sofer, pointing to local-currency access for the Israeli investor base that has been following the Alpha DaRT story.
